K

Klotho Neurosciences Inc
D

KLTO

0.58520
USD
-0.03
(-5.48%)
مغلق
حجم التداول
10,736
الربح لكل سهم
0
العائد الربحي
-
P/E
-1
حجم السوق
35,916,319
المقالات

العنوان: Klotho Neurosciences Inc

القطاع: Healthcare
الصناعة: Biotechnology
Klotho Neurosciences Inc is in the development of essential medicines for the treatment of chronic diseases: Cancer, Cardiovascular, and Neurodegenerative disorders. The Company currently has acquired two licensed platforms: a generic drugportfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and a proprietary, patented gene therapy platform which uses a gene therapy approach to introduce a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases. Company pipeline includes KLTO 101, KLTO 202, KLTO 301.